FindMyRecallSubscribe
Class II: temporary or reversible health riskCompleted

Dr. Reddy's Laboratories Tizanidine Tablets Recall

Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd

Dr. Reddy's Laboratories, Inc. · Princeton, NJ

Risk level
Class II
Reported by FDA
Jan 17, 2024
Recall ID
D-0223-2024
Check your lot numberHow we source this data

Summary

Dr. Reddy's Laboratories recalled Tizanidine Tablets starting Jan 2, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0223-2024 on Jan 17, 2024. Reason: Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets. Status: Completed.

Why it was recalled

Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.

Product description

Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-180-15

Lot numbers, UPCs & expiration codes

Lot #: T2304007, Exp 7/31/2026

Where it was sold

USA Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0223-2024
Classification
Class II
Status
Completed
Recall initiated
Jan 2, 2024
FDA report date
Jan 17, 2024
Quantity
38,952 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Dr. Reddy's Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-0223-2024, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Completed
Country
United States
Event ID
93713
Address
107 College Rd E
Code information
Lot #: T2304007, Exp 7/31/2026
Postal code
08540-6623
Report date
Jan 17, 2024
Product type
Drugs
Recall number
D-0223-2024
Classification
Class II
Recalling firm
Dr. Reddy's Laboratories, Inc.
Product quantity
38,952 bottles
Reason for recall
Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-180-15
Distribution pattern
USA Nationwide
Recall initiation date
Jan 2, 2024
Initial firm notification
Letter
Center classification date
Jan 11, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0223-2024, published Jan 17, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls